Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Fluoropyrimidine Activity WP1601,0.0023993407838628876,inf,inf,"['RRM2', 'UCK1']",0.24473275995401453,0,0,2
2,Amyotrophic lateral sclerosis (ALS) WP2447,0.005416042870225693,11.882142857142858,62.00565341967874,"['NEFM', 'NOS1', 'NEFH']",0.27621818638151036,0,0,3
3,Hypertrophy Model WP516,0.013484337914057511,19.654867256637168,84.63830869263258,"['WDR1', 'IL18']",0.45846748907795537,0,0,2
4,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.028363388477281693,5.386363636363637,19.189761285258164,"['NEFM', 'NOS1', 'NEFH']",0.5061026480471775,0,0,3
5,Serotonin Transporter Activity WP1455,0.04918712680786515,inf,inf,['NOS1'],0.5061026480471775,0,0,1
6,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.04918712680786515,inf,inf,['HEY1'],0.5061026480471775,0,0,1
7,NO metabolism in cystic fibrosis WP4947,0.04918712680786515,inf,inf,['NOS1'],0.5061026480471775,0,0,1
8,Pyrimidine metabolism and related diseases WP4225,0.04918712680786515,inf,inf,['RRM2'],0.5061026480471775,0,0,1
9,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.09597500473936092,19.49122807017544,45.680957543181336,['HEXIM1'],0.5061026480471775,0,0,1
10,Biomarkers for pyrimidine metabolism disorders WP4584,0.09597500473936092,19.49122807017544,45.680957543181336,['RRM2'],0.5061026480471775,0,0,1
11,Effects of nitric oxide WP1995,0.09597500473936092,19.49122807017544,45.680957543181336,['NOS1'],0.5061026480471775,0,0,1
12,Corticotropin-releasing hormone signaling pathway WP2355,0.13144157463778652,3.5591311343523735,7.222163362581458,"['IL18', 'FOSL2']",0.5061026480471775,0,0,2
13,IL1 and megakaryocytes in obesity WP2865,0.14047959378548147,9.741228070175438,19.119040541376922,['IL18'],0.5061026480471775,0,0,1
14,Major receptors targeted by epinephrine and norepinephrine WP4589,0.14047959378548147,9.741228070175438,19.119040541376922,['ADRA2C'],0.5061026480471775,0,0,1
15,Matrix Metalloproteinases WP129,0.14047959378548147,9.741228070175438,19.119040541376922,['MMP15'],0.5061026480471775,0,0,1
16,Monoamine Transport WP727,0.14047959378548147,9.741228070175438,19.119040541376922,['NOS1'],0.5061026480471775,0,0,1
17,Overview of nanoparticle effects WP3287,0.14047959378548147,9.741228070175438,19.119040541376922,['LAMA3'],0.5061026480471775,0,0,1
18,Heart Development WP1591,0.14047959378548147,9.741228070175438,19.119040541376922,['HEY1'],0.5061026480471775,0,0,1
19,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.14047959378548147,9.741228070175438,19.119040541376922,['PTTG1'],0.5061026480471775,0,0,1
20,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.18281137608058498,6.491228070175438,11.030546388048158,['ACTC1'],0.5061026480471775,0,0,1
21,Cardiac Progenitor Differentiation WP2406,0.18281137608058498,6.491228070175438,11.030546388048158,['ACTC1'],0.5061026480471775,0,0,1
22,TYROBP causal network in microglia WP3945,0.18281137608058498,6.491228070175438,11.030546388048158,['IL18'],0.5061026480471775,0,0,1
23,Urea cycle and associated pathways WP4595,0.18281137608058498,6.491228070175438,11.030546388048158,['NOS1'],0.5061026480471775,0,0,1
24,Development and heterogeneity of the ILC family WP3893,0.18281137608058498,6.491228070175438,11.030546388048158,['IL18'],0.5061026480471775,0,0,1
25,Nucleotide metabolism WP404,0.18281137608058498,6.491228070175438,11.030546388048158,['RRM2'],0.5061026480471775,0,0,1
26,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.18281137608058498,6.491228070175438,11.030546388048158,['FOXO4'],0.5061026480471775,0,0,1
27,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.18281137608058498,6.491228070175438,11.030546388048158,['FOXO4'],0.5061026480471775,0,0,1
28,RAS and bradykinin pathways in COVID-19 WP4969,0.18281137608058498,6.491228070175438,11.030546388048158,['NOS1'],0.5061026480471775,0,0,1
29,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.18281137608058498,6.491228070175438,11.030546388048158,['NOS1'],0.5061026480471775,0,0,1
30,Regulation of Microtubule Cytoskeleton WP2038,0.18281137608058498,6.491228070175438,11.030546388048158,['PARD6A'],0.5061026480471775,0,0,1
31,Male infertility WP4673,0.1841644495785731,2.7926675094816686,4.7249872512710205,"['CCNA1', 'NOS1']",0.5061026480471775,0,0,2
32,Pyrimidine metabolism WP4022,0.22077315406621537,2.441371681415929,3.6879838074043287,"['RRM2', 'UCK1']",0.5061026480471775,0,0,2
33,Striated Muscle Contraction Pathway WP383,0.223075542802484,4.866228070175438,7.300533396461499,['ACTC1'],0.5061026480471775,0,0,1
34,Monoamine GPCRs WP58,0.223075542802484,4.866228070175438,7.300533396461499,['ADRA2C'],0.5061026480471775,0,0,1
35,Neural Crest Cell Migration during Development WP4564,0.223075542802484,4.866228070175438,7.300533396461499,['EPHB3'],0.5061026480471775,0,0,1
36,Neural Crest Cell Migration in Cancer WP4565,0.223075542802484,4.866228070175438,7.300533396461499,['EPHB3'],0.5061026480471775,0,0,1
37,Neural Crest Differentiation WP2064,0.223075542802484,4.866228070175438,7.300533396461499,['MITF'],0.5061026480471775,0,0,1
38,Gastric Cancer Network 1 WP2361,0.223075542802484,4.866228070175438,7.300533396461499,['CCNA1'],0.5061026480471775,0,0,1
39,Glycosylation and related congenital defects WP4521,0.223075542802484,4.866228070175438,7.300533396461499,['MPDU1'],0.5061026480471775,0,0,1
40,RANKL/RANK signaling pathway WP2018,0.223075542802484,4.866228070175438,7.300533396461499,['MITF'],0.5061026480471775,0,0,1
41,Cell cycle WP179,0.25792123471811873,2.168141592920354,2.9380509110897055,"['CCNA1', 'PTTG1']",0.5061026480471775,0,0,2
42,Alpha 6 Beta 4 signaling pathway WP244,0.26137223799130094,3.8912280701754387,5.221287524783652,['LAMA3'],0.5061026480471775,0,0,1
43,AMP-activated protein kinase (AMPK) signaling WP1403,0.26137223799130094,3.8912280701754387,5.221287524783652,['CCNA1'],0.5061026480471775,0,0,1
44,Kit receptor signaling pathway WP304,0.26137223799130094,3.8912280701754387,5.221287524783652,['MITF'],0.5061026480471775,0,0,1
45,Kynurenine Pathway and links to Cellular Senescence WP5044,0.26137223799130094,3.8912280701754387,5.221287524783652,['NOS1'],0.5061026480471775,0,0,1
46,Canonical and non-canonical Notch signaling WP3845,0.26137223799130094,3.8912280701754387,5.221287524783652,['HEY1'],0.5061026480471775,0,0,1
47,NO/cGMP/PKG mediated Neuroprotection WP4008,0.26137223799130094,3.8912280701754387,5.221287524783652,['NOS1'],0.5061026480471775,0,0,1
48,Endochondral Ossification with Skeletal Dysplasias WP4808,0.26137223799130094,3.8912280701754387,5.221287524783652,['SLC38A2'],0.5061026480471775,0,0,1
49,Endochondral Ossification WP474,0.26137223799130094,3.8912280701754387,5.221287524783652,['SLC38A2'],0.5061026480471775,0,0,1
50,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.26137223799130094,3.8912280701754387,5.221287524783652,['IL18'],0.5061026480471775,0,0,1
51,Prostaglandin Synthesis and Regulation WP98,0.26137223799130094,3.8912280701754387,5.221287524783652,['MITF'],0.5061026480471775,0,0,1
52,Hepatitis C and Hepatocellular Carcinoma WP3646,0.26137223799130094,3.8912280701754387,5.221287524783652,['RRM2'],0.5061026480471775,0,0,1
53,Vitamin D Receptor Pathway WP2877,0.2951721955254513,1.9495575221238939,2.3788430297156236,"['CEACAM1', 'NINJ1']",0.5061026480471775,0,0,2
54,IL-4 signaling pathway WP395,0.2977967969230457,3.241228070175439,3.926241898602432,['SOCS5'],0.5061026480471775,0,0,1
55,AGE/RAGE pathway WP2324,0.2977967969230457,3.241228070175439,3.926241898602432,['FOXO4'],0.5061026480471775,0,0,1
56,Common Pathways Underlying Drug Addiction WP2636,0.2977967969230457,3.241228070175439,3.926241898602432,['PPP1CC'],0.5061026480471775,0,0,1
57,Cytosolic DNA-sensing pathway WP4655,0.2977967969230457,3.241228070175439,3.926241898602432,['IL18'],0.5061026480471775,0,0,1
58,Folate Metabolism WP176,0.2977967969230457,3.241228070175439,3.926241898602432,['NOS1'],0.5061026480471775,0,0,1
59,Phosphodiesterases in neuronal function WP4222,0.2977967969230457,3.241228070175439,3.926241898602432,['NOS1'],0.5061026480471775,0,0,1
60,Focal Adhesion WP306,0.31372135231745474,1.8558786346396965,2.1514274929046153,"['PPP1CC', 'LAMA3']",0.5061026480471775,0,0,2
61,CAMKK2  Pathway WP4874,0.33243997469765585,2.7769423558897244,3.0582354043820135,['NOS1'],0.5061026480471775,0,0,1
62,Vitamin A and carotenoid metabolism WP716,0.33243997469765585,2.7769423558897244,3.0582354043820135,['RBP2'],0.5061026480471775,0,0,1
63,Ectoderm Differentiation WP2858,0.33243997469765585,2.7769423558897244,3.0582354043820135,['PLCXD3'],0.5061026480471775,0,0,1
64,Notch Signaling Pathway Netpath WP61,0.33243997469765585,2.7769423558897244,3.0582354043820135,['HEY1'],0.5061026480471775,0,0,1
65,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.33243997469765585,2.7769423558897244,3.0582354043820135,['PPP1CC'],0.5061026480471775,0,0,1
66,Glycogen Synthesis and Degradation WP500,0.33243997469765585,2.7769423558897244,3.0582354043820135,['PHKA1'],0.5061026480471775,0,0,1
67,Hippo-Merlin Signaling Dysregulation WP4541,0.33243997469765585,2.7769423558897244,3.0582354043820135,['PPP1CC'],0.5061026480471775,0,0,1
68,Sleep regulation WP3591,0.36538816406891644,2.428728070175439,2.4452313436522846,['IL18'],0.5480822461033746,0,0,1
69,"GPCRs, Class A Rhodopsin-like WP455",0.38655625568749147,1.5561061946902655,1.4790445013631794,"['GPR12', 'ADRA2C']",0.5699409514876099,0,0,2
70,Acute viral myocarditis WP4298,0.39672360348647356,2.1578947368421053,1.9950070315477941,['NOS1'],0.5699409514876099,0,0,1
71,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.39672360348647356,2.1578947368421053,1.9950070315477941,['NOS1'],0.5699409514876099,0,0,1
72,Glucocorticoid Receptor Pathway WP2880,0.42652457489148055,1.9412280701754385,1.654091890509569,['TSC22D3'],0.6039361299595087,0,0,1
73,Metabolic reprogramming in colon cancer WP4290,0.45486559249815955,1.7639553429027113,1.3895616508447175,['SLC16A3'],0.6039361299595087,0,0,1
74,Glioblastoma signaling pathways WP2261,0.45486559249815955,1.7639553429027113,1.3895616508447175,['FOXO4'],0.6039361299595087,0,0,1
75,"GPCRs, Other WP117",0.45486559249815955,1.7639553429027113,1.3895616508447175,['GPR162'],0.6039361299595087,0,0,1
76,Retinoblastoma gene in cancer WP2446,0.45486559249815955,1.7639553429027113,1.3895616508447175,['RRM2'],0.6039361299595087,0,0,1
77,Ciliary landscape WP4352,0.4559125686949233,1.3390296002441258,1.0517464544606727,"['TTC30A', 'NEFM']",0.6039361299595087,0,0,2
78,TGF-beta Signaling Pathway WP366,0.4818175826263845,1.6162280701754386,1.1801530829802775,['PARD6A'],0.6300691465114259,0,0,1
79,Wnt signaling pathway and pluripotency WP399,0.5074480549462342,1.4912280701754386,1.0115908576788883,['ZBTB33'],0.6457829654062327,0,0,1
80,G1 to S cell cycle control WP45,0.5074480549462342,1.4912280701754386,1.0115908576788883,['CCNA1'],0.6457829654062327,0,0,1
81,Myometrial relaxation and contraction pathways WP289,0.5206267228166194,1.174577634754626,0.7666726123290565,"['ACTC1', 'NOS1']",0.6457829654062327,0,0,2
82,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5206267228166194,1.174577634754626,0.7666726123290565,"['LAMA3', 'NOS1']",0.6457829654062327,0,0,2
83,Integrated breast cancer pathway WP1984,0.5318212656286623,1.3840852130325814,0.8739775807105917,['FOSL2'],0.6457829654062327,0,0,1
84,Ras signaling WP4223,0.5318212656286623,1.3840852130325814,0.8739775807105917,['FOXO4'],0.6457829654062327,0,0,1
85,Alzheimer's disease WP2059,0.5549983729129014,1.2912280701754386,0.7602623005953524,['NOS1'],0.6506877475530568,0,0,1
86,Melanoma WP4685,0.5549983729129014,1.2912280701754386,0.7602623005953524,['MITF'],0.6506877475530568,0,0,1
87,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5549983729129014,1.2912280701754386,0.7602623005953524,['MMP15'],0.6506877475530568,0,0,1
88,Small cell lung cancer WP4658,0.5770375850108809,1.2099780701754386,0.6653038718059462,['LAMA3'],0.6613239738326949,0,0,1
89,Osteoblast differentiation WP4787,0.5770375850108809,1.2099780701754386,0.6653038718059462,['HEY1'],0.6613239738326949,0,0,1
90,22q11.2 copy number variation syndrome WP4657,0.5979943014078148,1.1382868937048503,0.585277587315061,['ACTC1'],0.6702793268527155,0,0,1
91,Insulin Signaling WP481,0.5979943014078148,1.1382868937048503,0.585277587315061,['EHD1'],0.6702793268527155,0,0,1
92,Nuclear Receptors Meta-Pathway WP2882,0.6339943114523019,0.9419382689402115,0.42925567804026804,"['TSC22D3', 'SLC5A3']",0.7029067366101608,0,0,2
93,IL-18 signaling pathway WP4754,0.6466105088735951,0.9190897597977244,0.400733393519283,"['UCK1', 'IL18']",0.7091857194097494,0,0,2
94,Spinal Cord Injury WP2431,0.6720132386320457,0.9197994987468672,0.3655993645587398,['NOS1'],0.7140140660465485,0,0,1
95,NRF2 pathway WP2884,0.6720132386320457,0.9197994987468672,0.3655993645587398,['SLC5A3'],0.7140140660465485,0,0,1
96,Gastrin signaling pathway WP4659,0.6720132386320457,0.9197994987468672,0.3655993645587398,['CHGA'],0.7140140660465485,0,0,1
97,EGF/EGFR signaling pathway WP437,0.688299217033395,0.8775917065390749,0.3278082580864358,['FOXO4'],0.7237785581175906,0,0,1
98,Breast cancer pathway WP4262,0.7037832065744041,0.8390541571319603,0.29474706865091194,['HEY1'],0.7325090517407064,0,0,1
99,Calcium Regulation in the Cardiac Cell WP536,0.7584546459590696,0.7134502923976608,0.19724922641330098,['GJD2'],0.7814381200790415,0,0,1
100,Circadian rhythm related genes WP3594,0.7927773650982803,0.6412280701754386,0.1489013957237491,['PPP1CC'],0.8086329124002459,0,0,1
101,VEGFA-VEGFR2 Signaling Pathway WP3888,0.806327481198629,0.6906196213425129,0.1486664501801969,"['CHAC1', 'FOXO4', 'BMX']",0.8143109216065362,0,0,3
102,PI3K-Akt signaling pathway WP4172,0.8475779734674435,0.5328947368421053,0.08812610282453855,['LAMA3'],0.8475779734674435,0,0,1
